Vivanza Biosciences Ltd — Important, 07-05-2026: Company Update

Vivanza Biosciences has announced it is exempt from disclosing related party transactions for the recent quarter and financial year. This is because its paid-up equity capital was 4 Cr and net worth was 4.02 Cr as of the previous financial year-end. These figures are below the thresholds of 10 Cr paid-up capital and 25 Cr net worth, which require such disclosures from companies. This means shareholders will not see a specific related party transaction report from the company at this time. The company stated it will comply if it crosses these thresholds in the future.